162 related articles for article (PubMed ID: 6782251)
1. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder.
Koontz WW; Prout GR; Smith W; Frable WJ; Minnis JE
J Urol; 1981 Mar; 125(3):307-12. PubMed ID: 6782251
[No Abstract] [Full Text] [Related]
2. [Intravesical application of thio-tepa for preventing postoperative recurrence of bladder carcinoma].
Zhang SX; Deng XZ; Tang XD
Zhonghua Wai Ke Za Zhi; 1986 Aug; 24(8):486-7, 510. PubMed ID: 3102180
[No Abstract] [Full Text] [Related]
3. The effect of intravesical thio-tepa on normal and tumor urothelium.
Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
[TBL] [Abstract][Full Text] [Related]
4. The effects of intravesical instillation of Thio-Tepa on the recurrence rate of bladder tumors.
Asahi T; Matsumura Y; Tanahashi T; Yoshimoto J; Kaneshige T; Fujita Y; Ohmori H
Acta Med Okayama; 1980 Feb; 34(1):43-9. PubMed ID: 6446839
[TBL] [Abstract][Full Text] [Related]
5. The role of intravesical thiotepa in the management of superficial bladder cancer. National Bladder Cancer Collaborative Group A.
Cancer Res; 1977 Aug; 37(8 Pt 2):2916-7. PubMed ID: 406040
[TBL] [Abstract][Full Text] [Related]
6. Intravesical thiotepa in prevention of recurrence of bladder tumour.
Ghosal SK; Sen DK
J Indian Med Assoc; 1980 Nov; 75(9):173-4. PubMed ID: 6785360
[No Abstract] [Full Text] [Related]
7. The prophylactic use of thio-TEPA in transitional cell carcinoma of the bladder.
Wescott JW
J Urol; 1966 Dec; 96(6):913-8. PubMed ID: 4959545
[No Abstract] [Full Text] [Related]
8. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
Nocks BN; Nieh PT; Prout GR
J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
[TBL] [Abstract][Full Text] [Related]
9. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
Nieh PT; Daly JJ; Irwin RJ; Prout GR
Invest Urol; 1979 May; 16(6):486-8. PubMed ID: 109416
[TBL] [Abstract][Full Text] [Related]
10. Optimal intravesical dosage of thio-tepa in the prophylaxis of recurrent bladder papillomatosis.
Oravisto KJ
Scand J Urol Nephrol; 1972; 6(1):26-8. PubMed ID: 4626940
[No Abstract] [Full Text] [Related]
11. The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.
Dobrzecki W; Kaczmarek A
Int Urol Nephrol; 1977; 9(2):145-9. PubMed ID: 412808
[TBL] [Abstract][Full Text] [Related]
12. Clinical and experimental projects on chemotherapy of bladder tumours.
Pavone-Macaluso M; Rausa L; Gebbia N; Caramia G; Rizzo FP; Arena E; Tessitore V; Vecchioni M
S Afr Med J; 1974 Mar; 48(15):631-6. PubMed ID: 4378338
[No Abstract] [Full Text] [Related]
13. Intravesical chemotherapy in a controlled trial with thio-tepa versus doxorubicin hydrochloride.
Horn Y; Eidelman A; Walach N; Ilian M
J Urol; 1981 May; 125(5):652-4. PubMed ID: 6785455
[No Abstract] [Full Text] [Related]
14. EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Schulman CC; Rozencweig M; Staquet M; Kenis Y; Sylvester R
Eur Urol; 1976; 2(6):271-3. PubMed ID: 829223
[TBL] [Abstract][Full Text] [Related]
15. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
Boyd PJ; Burnand KG
Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 803851
[No Abstract] [Full Text] [Related]
16. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
[TBL] [Abstract][Full Text] [Related]
17. [Own experiences with the treatment of papillomatous bladder neoplasms by intracystic administration of Thio-Tepa].
Dobrzecki W; Kaczmarek A
Pol Przegl Chir; 1977 Jun; 49(6a):743-8. PubMed ID: 407554
[No Abstract] [Full Text] [Related]
18. [Preliminary results of a randomized study between intravesical adriamycin and thio-tepa in the treatment of superficial tumors of bladder].
Allona Moncada A; Santos García Vaquero I; Polo Villar G; Díaz González R; González Martín M; Zuloaga Gómez A; Martínez Torres JL; Rodríguez Alvarez J; Duarte Vázquez JJ; Megino López JF
Arch Esp Urol; 1984; 37(2):113-22. PubMed ID: 6431914
[No Abstract] [Full Text] [Related]
19. [Thio-Tepa in the chemotherapy and chemical prevention of papillary neoplasms of the bladder].
Delzotto L; Viggiano G; Marchini M; Barbui PE
Minerva Med; 1977 Jun; 68(28):1957-60. PubMed ID: 406584
[No Abstract] [Full Text] [Related]
20. Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder.
Csellár M; Csontai A
Int Urol Nephrol; 1979; 11(1):39-44. PubMed ID: 112079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
